Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 5.58%1.36B | ---- | 110.31%3.13B | ---- | 81.63%1.29B | ---- | 126.02%1.49B | ---- | 77.02%709.61M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -0.58%-353.18M | ---- | -14.52%-720.58M | ---- | -28.14%-351.15M | ---- | -40.13%-629.2M | ---- | -22.11%-274.03M |
| Attributable subsidiary (profit) loss | ---- | -2.89%342.8M | ---- | -22.52%903.52M | ---- | -36.88%353.01M | ---- | -15.60%1.17B | ---- | -19.51%559.32M |
| Impairment and provisions: | ---- | 100.31%3.2M | ---- | 11.86%23.33M | ---- | -91.69%1.6M | ---- | -99.68%20.86M | ---- | 116.01%19.21M |
| -Impairment of trade receivables (reversal) | ---- | 100.31%3.2M | ---- | 10.61%15.24M | ---- | -91.69%1.6M | ---- | -45.90%13.78M | ---- | 116.01%19.21M |
| -Other impairments and provisions | ---- | ---- | ---- | 14.30%8.09M | ---- | ---- | ---- | -99.89%7.08M | ---- | ---- |
| Revaluation surplus: | ---- | 43.53%-25.3M | ---- | 45.73%-56.46M | ---- | 31.39%-44.8M | ---- | -9.73%-104.04M | ---- | -36.62%-65.29M |
| -Other fair value changes | ---- | 43.53%-25.3M | ---- | 45.73%-56.46M | ---- | 31.39%-44.8M | ---- | -9.73%-104.04M | ---- | -36.62%-65.29M |
| Asset sale loss (gain): | ---- | -766.60%-358.08M | ---- | 124.88%158.8M | ---- | -27.60%53.72M | ---- | 344.02%70.62M | ---- | 2,109.41%74.19M |
| -Loss (gain) from sale of subsidiary company | ---- | -768.71%-358M | ---- | 156.46%158.8M | ---- | -22.14%53.54M | ---- | 382.99%61.92M | ---- | 1,953.21%68.76M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -143.96%-80K | ---- | -99.93%6K | ---- | -96.65%182K | ---- | 20,804.76%8.7M | ---- | 60,233.33%5.43M |
| Depreciation and amortization: | ---- | -0.30%115.54M | ---- | -5.32%226.84M | ---- | -6.47%115.89M | ---- | -12.18%239.57M | ---- | -6.63%123.91M |
| -Depreciation | ---- | ---- | ---- | 0.37%156.52M | ---- | ---- | ---- | -4.70%155.94M | ---- | ---- |
| -Amortization of intangible assets | ---- | 10.49%13.2M | ---- | -22.07%24.38M | ---- | -24.30%11.95M | ---- | -11.65%31.29M | ---- | -8.27%15.78M |
| Financial expense | ---- | -38.48%54.35M | ---- | 5.78%178.65M | ---- | 7.11%88.33M | ---- | 7.27%168.89M | ---- | 9.11%82.47M |
| Exchange Loss (gain) | ---- | -575.15%-37.26M | ---- | -35.51%43.34M | ---- | -85.79%7.84M | ---- | 23.06%67.2M | ---- | 252.60%55.18M |
| Special items | ---- | -21.16%124.78M | ---- | -12.11%275.87M | ---- | -3.33%158.26M | ---- | 26.26%313.87M | ---- | 19.48%163.72M |
| Operating profit before the change of operating capital | ---- | -26.56%1.23B | ---- | 48.59%4.16B | ---- | 15.42%1.67B | ---- | 15.90%2.8B | ---- | 21.01%1.45B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -126.33%-238K | ---- | 53.60%4.16M | ---- | 668.55%904K | ---- | 4,083.82%2.71M | ---- | 98.25%-159K |
| Accounts receivable (increase)decrease | ---- | 72.32%-38.41M | ---- | 48.94%72.25M | ---- | -621.97%-138.76M | ---- | 10,974.89%48.51M | ---- | -398.81%-19.22M |
| Accounts payable increase (decrease) | ---- | -48.89%-354.01M | ---- | -191.16%-122.42M | ---- | -129.54%-237.76M | ---- | 276.52%134.3M | ---- | 449.41%804.98M |
| prepayments (increase)decrease | ---- | 52.67%45.22M | ---- | 26.27%-27.73M | ---- | -14.85%29.62M | ---- | -183.06%-37.61M | ---- | 115.43%34.78M |
| Special items for working capital changes | ---- | -90.26%21.05M | ---- | 40.77%725.81M | ---- | 134.02%216.06M | ---- | 46.22%515.62M | ---- | -51.45%92.32M |
| Cash from business operations | ---- | -41.54%901.15M | ---- | 38.96%4.82B | ---- | -34.71%1.54B | ---- | 26.48%3.47B | ---- | 103.57%2.36B |
| Other taxs | ---- | -19.32%-284.75M | ---- | -22.75%-361.32M | ---- | -46.27%-238.65M | ---- | -21.72%-294.35M | ---- | -5.28%-163.15M |
| Interest received - operating | ---- | -32.04%48.46M | ---- | -58.38%131.85M | ---- | -35.01%71.31M | ---- | 323.61%316.77M | ---- | 125.77%109.73M |
| Special items of business | -58.04%1.16B | ---- | -131.05%-102.15M | ---- | 57.34%2.76B | ---- | -9.25%329.04M | ---- | 30.83%1.76B | ---- |
| Net cash from operations | -58.04%1.16B | -51.62%664.86M | -131.05%-102.15M | 31.48%4.59B | 57.34%2.76B | -40.45%1.37B | -9.25%329.04M | 35.56%3.49B | 30.83%1.76B | 119.05%2.31B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -42.06%262.49M | ---- | 539.91%580.79M | ---- | 234.00%453.05M | ---- | -64.43%90.76M | ---- | 12.10%135.64M |
| Dividend received - investment | ---- | ---- | ---- | --291K | ---- | --291K | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | 100.10%1M | ---- | 1.83%-499.5M | ---- | ---999.5M | ---- | -207.32%-508.8M | ---- | ---- |
| Decrease in deposits (increase) | ---- | 136.96%2.11B | ---- | -93.31%-8.5B | ---- | -262.18%-5.7B | ---- | -195.15%-4.4B | ---- | -170.78%-1.57B |
| Sale of fixed assets | ---- | 651.76%639K | ---- | 72.97%787K | ---- | -96.12%85K | ---- | -39.41%455K | ---- | 1,358.67%2.19M |
| Purchase of fixed assets | ---- | -17.97%-187.52M | ---- | 10.41%-409.78M | ---- | 11.23%-158.95M | ---- | 5.13%-457.39M | ---- | 5.79%-179.05M |
| Selling intangible assets | ---- | ---- | ---- | --207K | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | ---- | -181.12%-15.12M | ---- | 1.09%-16.4M | ---- | -33.79%-5.38M | ---- | 37.49%-16.58M | ---- | 42.78%-4.02M |
| Sale of subsidiaries | ---- | 46,116.04%48.99M | ---- | -3.14%9.29M | ---- | -92.66%106K | ---- | 154.31%9.59M | ---- | 108.60%1.45M |
| Recovery of cash from investments | ---- | 163.62%237.68M | ---- | 235.29%744.09M | ---- | ---373.56M | ---- | ---550.01M | ---- | ---- |
| Cash on investment | ---- | ---538.92M | ---- | 33.38%-429.61M | ---- | ---- | ---- | -45.79%-644.9M | ---- | 150.79%136.06M |
| Other items in the investment business | 111.70%958.66M | ---- | 89.68%-135.53M | ---- | -63.39%-8.19B | ---- | 57.36%-1.31B | ---- | -168.63%-5.01B | ---- |
| Net cash from investment operations | 111.70%958.66M | 128.25%1.92B | 89.68%-135.53M | -31.62%-8.52B | -63.39%-8.19B | -357.82%-6.79B | 57.36%-1.31B | -246.46%-6.48B | -168.63%-5.01B | -224.50%-1.48B |
| Net cash before financing | 139.00%2.12B | 147.70%2.58B | 75.84%-237.68M | -31.78%-3.94B | -66.65%-5.43B | -756.23%-5.41B | 63.78%-983.78M | -142.71%-2.99B | -521.04%-3.26B | 38.29%824.94M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---75.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuing shares | ---- | -0.10%58.25M | ---- | 226.57%112.05M | ---- | 70.36%58.31M | ---- | 247.60%34.31M | ---- | 335.72%34.23M |
| Interest paid - financing | ---- | 69.34%-3.24M | ---- | 7.31%-20.21M | ---- | 6.06%-10.57M | ---- | 13.12%-21.8M | ---- | 9.76%-11.25M |
| Dividends paid - financing | ---- | -6.24%-503.38M | ---- | -14.30%-600.67M | ---- | -54.63%-473.83M | ---- | -20.79%-525.51M | ---- | 29.57%-306.44M |
| Absorb investment income | ---- | --4.88M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -121.27%-934.82M | ---- | -91.24%-533.51M | ---- | -1,655.00%-422.48M | ---- | -69.95%-278.98M | ---- | 65.28%-24.07M |
| Other items of the financing business | -80.35%-1.91B | ---216.42M | 22.92%-275.43M | -100.26%-4.06M | -213.12%-1.06B | ---- | -205.72%-357.33M | 3,313.93%1.54B | 272.05%938.11M | 2,602.03%1.35B |
| Net cash from financing operations | -80.35%-1.91B | -92.83%-1.68B | 22.92%-275.43M | -265.23%-1.08B | -213.12%-1.06B | -187.91%-869.44M | -205.72%-357.33M | 205.95%655.86M | 272.05%938.11M | 298.00%989.02M |
| Effect of rate | -154.84%-37.16M | -355.75%-16.73M | -150.25%-2.96M | -17.31%16.47M | -133.67%-14.58M | -89.07%6.54M | 127.94%5.9M | -77.72%19.92M | -64.78%43.31M | -6.56%59.85M |
| Net Cash | 103.14%203.56M | 114.42%905.84M | 61.74%-513.11M | -115.33%-5.02B | -179.81%-6.49B | -446.36%-6.28B | 52.66%-1.34B | -136.57%-2.33B | -116.82%-2.32B | 1,769.22%1.81B |
| Begining period cash | -57.47%3.7B | -57.47%3.7B | -57.47%3.7B | -20.98%8.71B | -20.98%8.71B | -20.98%8.71B | -20.98%8.71B | 141.99%11.02B | 141.99%11.02B | 141.99%11.02B |
| Cash at the end | 75.71%3.87B | 88.92%4.59B | -56.76%3.19B | -57.47%3.7B | -74.81%2.2B | -81.14%2.43B | -9.71%7.37B | -20.98%8.71B | 142.41%8.74B | 173.47%12.89B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | 38.77%2.54B | 38.77%2.54B | ---- | -49.55%2.66B | -80.42%1.83B | -80.42%1.83B | ---- | -41.75%5.27B | --9.33B | 268.32%9.33B |
| Cash and cash equivalent balance | 38.77%2.54B | 38.77%2.54B | ---- | -49.55%2.66B | -80.42%1.83B | -80.42%1.83B | ---- | -41.75%5.27B | --9.33B | 268.32%9.33B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young Accounting Firm | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.